Earnings News
Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.
Vertiv Q1 Surges on AI Demand, Lifts 2026 View; Stock Dips on In-Line Q2 Guide
Vertiv posted a strong first quarter with sales up 30% and raised its full-year and 2026 guidance, driven by robust demand for AI infrastructure. However, its stock edged lower as the second-quarter outlook aligned with analyst projections.
SoFi Shares Dip Ahead of Q1 Report as Investors Await $1 Billion Revenue Test
SoFi Technologies shares fell Tuesday as the market positioned for next week's first-quarter earnings report. The fintech must demonstrate it can sustain momentum after achieving $1 billion in quarterly revenue last year.
Nokia's Q1 Report to Showcase AI Strategy Amid Market Challenges
Nokia is set to release its first-quarter results, with analysts forecasting an adjusted operating profit of €253 million. The report will debut a new financial structure and highlight the company's recent AI infrastructure partnerships.
Opendoor Shares Surge on Strong Housing Data Ahead of Q1 Report
Opendoor Technologies shares advanced significantly Tuesday, buoyed by better-than-expected U.S. pending home sales data. Traders are now looking ahead to the company's first-quarter financial results scheduled for release next month.
Intel Q1 Earnings: AI Chip Supply Crunch Tests Turnaround Strategy
Intel faces its Q1 earnings report Thursday, with investors scrutinizing whether the chipmaker can meet surging AI server processor demand. Despite expected data center growth, overall revenue and earnings are projected to decline sharply.
Meta's Q1 Earnings to Gauge AI Investment Payoff Amid Rising Costs
Meta Platforms will announce first-quarter financial results on April 29, as investors assess whether advertising gains can sustain the company's aggressive artificial intelligence investments.
Pfizer Gains on FDA Priority Review for Padcev as Pipeline Pivots Post-COVID
Pfizer shares advanced after the FDA granted priority review for its Padcev bladder cancer therapy, setting an August decision. Investors await Q1 results to gauge progress in oncology and obesity drugs against fading COVID sales.
Analysts Boost Apple Outlook Ahead of Earnings, Highlight Memory Cost Divergence
Apple shares gained as Morgan Stanley reiterated a bullish $315 price target ahead of earnings, while BNP Paribas upgraded the stock and cut Qualcomm, citing diverging abilities to handle higher memory costs.
Microsoft's AI Investment Strategy Faces Critical Earnings Scrutiny
Microsoft shares declined 1.3% ahead of its April 29 earnings, with investors divided over whether massive AI investments will deliver returns. The company faces margin pressure as capital spending jumped 66% to $37.5 billion last quarter.
Intel Shares Retreat from 24-Year Peak as AI CPU Strategy Faces Earnings Scrutiny
Intel shares declined 3.5% to $66.08, pulling back from a 24-year high ahead of its April 23 earnings. The report is seen as a key test for whether AI spending is broadening to benefit CPU makers.
Boeing Showcases Chinook Drone Tech as Commercial Recovery Hinges on Q1 Earnings
Boeing is promoting advanced drone and autonomy features for its Chinook helicopter as investors await first-quarter earnings, with the commercial division's recovery and production targets under the microscope.
7-Eleven to Shutter 645 Stores, Delays North American IPO Amid Strategic Shift
Seven & i Holdings plans to close 645 7-Eleven stores in North America in fiscal 2026 while opening 205 new locations, reducing its total footprint. The company has postponed its planned North American IPO to fiscal 2027 or beyond.